Clinical Trial Update: Prevalence of POU4F3 and SLC17A8 Mutations

View source ↗

Summary

Terminated clinical trial assessing the prevalence of POU4F3 and SLC17A8 mutations in hereditary hearing loss; no results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hearing Loss

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Familial Deafness | Status: TERMINATED